J. E. Davis - 18 Feb 2026 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Feb 2026, 17:11:48 UTC
Prior SEC filing
28 Nov 2025
Next SEC filing
04 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Sean D. Mersten, Attorney in Fact for James E. Davis

Key filing fact

J. E. Davis filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 20 Feb 2026.

Key facts

  • This page summarizes J. E. Davis's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 20 Feb 2026, 17:11.

Change

  • Previous filing in this sequence was filed on 28 Nov 2025.
  • Current net transaction value: -$1,287,262.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001599837 Primary reporting owner

Davis J. E.

Relationship
CEO and President, Director
Address
500 PLAZA DRIVE, SECAUCUS
Signature
Sean D. Mersten, Attorney in Fact for James E. Davis
Signature date
20 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DGX transaction

Common Stock

Award

Transaction value
$0
Shares
+15,857
Change %
+13%
Price
$0.000000
Shares after
136,337
Date
18 Feb 2026
Ownership
Direct
Footnotes
F1
DGX transaction

Common Stock

Tax liability

Transaction value
$503,184
Shares
-2,396
Change %
-1.8%
Price
$210.01
Shares after
133,941
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2
DGX transaction

Common Stock

Tax liability

Transaction value
$784,078
Shares
-3,788
Change %
-2.8%
Price
$206.99
Shares after
130,153
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DGX transaction Derivative

Non-Qualifed Stock Option (right to buy)

Award

Transaction value
$0
Shares
+73,225
Change %
Price
$0.000000
Shares after
73,225
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
73,225
Exercise price
$204.96
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents an award of restricted stock units.

Footnote F2

Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Footnote F3

The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .